D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 69 Citations 15,859 322 World Ranking 4702 National Ranking 2326

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

His primary scientific interests are in Carcinogen, DNA, Biochemistry, Adduct and Endocrinology. His Carcinogen research is multidisciplinary, incorporating perspectives in Molecular biology, Genotoxicity, Metabolism and Pyrene. His DNA study combines topics in areas such as Chromatography, Tandem mass spectrometry, Stereochemistry and Cancer research.

His Biochemistry course of study focuses on Bacteria and Mutation frequency. Frederick A. Beland combines subjects such as Acetylation and In vivo with his study of Adduct. His Endocrinology research incorporates themes from Internal medicine, Adenoma and DNA methyltransferase.

His most cited work include:

  • An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. (343 citations)
  • Malachite Green: A Toxicological Review (334 citations)
  • A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. (225 citations)

What are the main themes of his work throughout his whole career to date?

Frederick A. Beland mainly focuses on Carcinogen, Biochemistry, DNA, Adduct and Molecular biology. Frederick A. Beland has researched Carcinogen in several fields, including Carcinogenesis, In vivo, Internal medicine and Endocrinology. His research integrates issues of microRNA, Epigenetics and DNA methylation in his study of Carcinogenesis.

His DNA research integrates issues from Chromatography, In vitro, Nucleotide and Benzopyrene. His studies examine the connections between Adduct and genetics, as well as such issues in Stereochemistry, with regards to Guanosine. His Molecular biology research incorporates elements of Cell growth, DNA damage, Mutation, Micronucleus test and Genotoxicity.

He most often published in these fields:

  • Carcinogen (33.53%)
  • Biochemistry (26.88%)
  • DNA (24.57%)

What were the highlights of his more recent work (between 2012-2021)?

  • Carcinogen (33.53%)
  • Cancer research (14.16%)
  • Pharmacology (8.38%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Carcinogen, Cancer research, Pharmacology, Epigenetics and Internal medicine. His Carcinogen research is multidisciplinary, incorporating elements of Molecular biology, In vivo, DNA and Genotoxicity. The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Cancer, microRNA and Transfection.

His Pharmacology research integrates issues from Metabolite and Apoptosis. His studies in Epigenetics integrate themes in fields like H3K4me3, Histone and DNA methylation. As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Endocrinology and frequently concerns with Fatty liver, Nonalcoholic fatty liver disease and Receptor.

Between 2012 and 2021, his most popular works were:

  • Carcinogenicity of glycidamide in B6C3F1 mice and F344/N rats from a two-year drinking water exposure (74 citations)
  • Effect of triclosan, triclocarban, 2,2′,4,4′-tetrabromodiphenyl ether, and bisphenol A on the iodide uptake, thyroid peroxidase activity, and expression of genes involved in thyroid hormone synthesis ☆ (55 citations)
  • IARC monographs: 40 years of evaluating carcinogenic hazards to humans (47 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

His primary areas of study are Carcinogen, Cancer research, microRNA, Cancer and Carcinogenesis. His studies deal with areas such as Molecular biology, Ovary and Harderian gland, Pathology as well as Carcinogen. In his study, Biochemistry is inextricably linked to Bladder cancer, which falls within the broad field of Molecular biology.

The various areas that Frederick A. Beland examines in his Cancer research study include Nonalcoholic fatty liver disease and Epigenetics. His microRNA study incorporates themes from Drug toxicity, Drug and Bioinformatics. His Carcinogenesis research includes elements of Tobacco smoke, Mutation, Cancer cell, Genome and Breast cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera.

Boudreau;Beland Fa.
Journal of Environmental Science and Health Part C-environmental Carcinogenesis & Ecotoxicology Reviews (2006)

679 Citations

Malachite Green: A Toxicological Review

Sandra J. Culp;Frederick A. Beland.
Journal of the American College of Toxicology (1996)

510 Citations

Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of a benzo[a]pyrenetetrahydrodiol epoxide-guanosine adduct

A. M. Jeffrey;K. W. Jennette;S. H. Blobstein;I. B. Weinstein.
Journal of the American Chemical Society (1976)

336 Citations

A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay.

Sandra J. Culp;David W. Gaylor;Winslow G. Sheldon;Lawrence S. Goldstein.
Carcinogenesis (1998)

336 Citations

DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice.

Goncalo Gamboa Da Costa;Mona I. Churchwell;L. Patrice Hamilton;Linda S. Von Tungeln.
Chemical Research in Toxicology (2003)

298 Citations

Toxicity and metabolism of malachite green and leucomalachite green during short-term feeding to Fischer 344 rats and B6C3F1 mice.

Sandra J. Culp;Lonnie R. Blankenship;Donna F. Kusewitt;Daniel R. Doerge.
Chemico-Biological Interactions (1999)

289 Citations

Formation and persistence of arylamine DNA adducts in vivo.

Frederick A. Beland;Fred F. Kadlubar.
Environmental Health Perspectives (1985)

271 Citations

DNA hypomethylation in the origin and pathogenesis of human diseases

Igor P. Pogribny;Frederick A. Beland.
Cellular and Molecular Life Sciences (2009)

256 Citations

Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis.

Frederick A. Beland;David T. Beranek;Kenneth L. Dooley;Robert H. Heflich.
Environmental Health Perspectives (1983)

248 Citations

E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells†‡

Volodymyr P. Tryndyak;Frederick A. Beland;Igor P. Pogribny.
International Journal of Cancer (2010)

247 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Frederick A. Beland

Peter P. Fu

Peter P. Fu

United States Food and Drug Administration

Publications: 92

Robert H. Heflich

Robert H. Heflich

United States Food and Drug Administration

Publications: 70

Miriam C. Poirier

Miriam C. Poirier

National Institutes of Health

Publications: 63

Ronald G. Harvey

Ronald G. Harvey

University of Chicago

Publications: 54

Robert J. Turesky

Robert J. Turesky

University of Minnesota

Publications: 46

Daniel R. Doerge

Daniel R. Doerge

United States Food and Drug Administration

Publications: 42

Igor P. Pogribny

Igor P. Pogribny

National Center for Toxicological Research

Publications: 42

David H. Phillips

David H. Phillips

King's College London

Publications: 41

Stephen S. Hecht

Stephen S. Hecht

University of Minnesota

Publications: 35

Daniel A. Casciano

Daniel A. Casciano

University of Arkansas at Little Rock

Publications: 32

Suse Broyde

Suse Broyde

New York University

Publications: 30

Nicholas E. Geacintov

Nicholas E. Geacintov

New York University

Publications: 29

Gary M. Williams

Gary M. Williams

New York Medical College

Publications: 29

Ivan Rusyn

Ivan Rusyn

Texas A&M University

Publications: 28

Herbert S. Rosenkranz

Herbert S. Rosenkranz

Florida Atlantic University

Publications: 27

Volker M. Arlt

Volker M. Arlt

King's College London

Publications: 26

Trending Scientists

Marcus Peinado

Marcus Peinado

Microsoft (United States)

B. Bosnich

B. Bosnich

University of Chicago

Gaohong He

Gaohong He

Dalian University of Technology

Stephen T. Liddle

Stephen T. Liddle

University of Manchester

T. Jonathan Davies

T. Jonathan Davies

University of British Columbia

Elaine W. Raines

Elaine W. Raines

University of Washington

Harry W. Schroeder

Harry W. Schroeder

University of Alabama at Birmingham

Harald Brüssow

Harald Brüssow

Nestlé (Switzerland)

Peter Berg

Peter Berg

University of Virginia

René M. Müri

René M. Müri

University of Bern

Tammie L.S. Benzinger

Tammie L.S. Benzinger

Washington University in St. Louis

David C. Musch

David C. Musch

University of Michigan–Ann Arbor

Robert L. Sutherland

Robert L. Sutherland

Garvan Institute of Medical Research

Alan D. Michelson

Alan D. Michelson

Harvard University

Michael A. Levine

Michael A. Levine

Children's Hospital of Philadelphia

Katrien Struyven

Katrien Struyven

Vrije Universiteit Brussel

Something went wrong. Please try again later.